IN8bio Appoints Jeremy Graff, Ph.D., to Board of Directors :

IN8bio Appoints Jeremy Graff, Ph.D., to Board of Directors

01.05.2023 - Dr. Jeremy Graff spent 17 years at Eli Lilly and Company, where he built and led the translational oncology group, supporting and advancing 31 clinical assets in Eli Lilly’s oncology portfolioHe is a highly respected industry leader in oncology with ... Seite 1

Related Keywords

Canada , Canadian , Eli Lilly , Jeremy Graff , Science Technology Committee , Nasdaq , Technology Committee , Cancer Zero , Chief Scientific Officer ,

© 2025 Vimarsana